Geisel, R., Schmitz, F., Fluit, A., & Labischinski, H. (2001). Emergence, Mechanism, and Clinical Implications of Reduced Glycopeptide Susceptibility in Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases, 20(10), 685. https://doi.org/10.1007/s100960100595
Chicago Style (17th ed.) CitationGeisel, R., F.J Schmitz, A.C Fluit, and H. Labischinski. "Emergence, Mechanism, and Clinical Implications of Reduced Glycopeptide Susceptibility in Staphylococcus Aureus." European Journal of Clinical Microbiology & Infectious Diseases 20, no. 10 (2001): 685. https://doi.org/10.1007/s100960100595.
MLA (9th ed.) CitationGeisel, R., et al. "Emergence, Mechanism, and Clinical Implications of Reduced Glycopeptide Susceptibility in Staphylococcus Aureus." European Journal of Clinical Microbiology & Infectious Diseases, vol. 20, no. 10, 2001, p. 685, https://doi.org/10.1007/s100960100595.